• Part III: Indexes to Diagnosis and Research Complications of Infectious Agents pp 70-86
[read]
[skim]
• Index pp 87-95
[read]
[skim]
• Front Matter pp R1-10
[read]
[skim]
• Part II: Disease Agents pp 9-69
[read]
[skim]
• Case Study 20: Legionaires' Disease: Description of an Epidemic of Pneumonia pp 436-444
[read]
[skim]
• B: Medical School Courses and Clerkships: Access Points for Integrating Environmental Medicine pp 97-120
[read]
[skim]
• Case Study 54: Childhood Asthma and Indoor Enviromental Risk Factors pp 893-903
[read]
[skim]
• Case Study 2: Seasonal Arsenic Exposure from Burning Chromium-Copper-Arsenate-Treated Wood pp 164-167
[read]
[skim]
• ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD pp 2-4
[read]
[skim]
• DETERMINING VACCINE NEED pp 5-7
[read]
[skim]
• PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS pp 14-19
[read]
[skim]
• INTRODUCING AN EFFECTIVE VACCINE pp 20-26
[read]
[skim]
• Appendix B: Glossary pp 145-156
[read]
[skim]
• 3 Existing Data Sources and Systems pp 39-58
[read]
[skim]
• 6 Methodological Approaches to Studying Health Outcomes Associated with the Current Immunization Schedule: Options, Feasibility, Ethical Issues, and Priorities pp 99-126
[read]
[skim]
